Assess the side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention

Joining Dr. Alan Brown to discuss the pharmacokinetic data behind drug interactions between treatments for complex lipid abnormalities is Dr. Barbara Wiggins, Pharm.D, clinical pharmacy specialist in cardiology at the Medical University of South Carolina and adjunct professor at the South Carolina... more

No votes yet

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service